Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Evolus, Inc.    EOLS

EVOLUS, INC.

(EOLS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

EVOLUS, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of investors that purchased Evolus, Inc.

10/30/2020 | 08:01am EST

NEW YORK, Oct. 30, 2020 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP  announces that a federal securities class action lawsuit has been filed in the United States District Court for the Southern District of New York  against  Evolus, Inc. ("Evolus" or the "Company") (NASDAQ: EOLS) on behalf of all persons or entities that purchased or otherwise acquired Evolus stock between February 1, 2019 and July 6, 2020, both dates inclusive (the "Class Period").

All investors who purchased shares of Evolus, Inc. and incurred losses are urged to contact the firm immediately at classmember@whafh.com or (800) 575-0735 or (212) 545-4774. You may obtain additional information concerning the action or join the case on our website, www.whafh.com.

If  you  have  incurred  losses  in  the  shares of Evolus, Inc., you may, no later than December 15, 2020,  request that the Court appoint you lead plaintiff of the proposed class.  Please contact Wolf Haldenstein to learn more about your rights as an investor in the shares of Evolus, Inc.   

CLICK HERE TO JOIN CASE

On July 6, 2020, the Initial Final Determination was issued by the United States  International Trade Commission ("ITC") in a case brought by Allergan and Medytox against Evolus, asserting that Evolus stole certain trade secrets to develop Jeuveau™. The ITC Judge determined that the Company misappropriated the botulinum toxin strain as well as the manufacturing processes that led to its development and manufacture. As a result, the ITC Judge recommended a ten-year long ban on the Company's ability to import Jeuveau™ into the United States and a ten-year-long cease and desist order preventing Evolus from selling Jeuveau™ in the United States.

On this news, the Company's share price declined materially, falling 37% over the course of two trading days, to close at $3.35 on July 8, 2020

Wolf Haldenstein has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country.  The firm has attorneys in various practice areas; and offices in New York, Chicago and San Diego.  The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly recognized by the courts, which have appointed it to major positions in complex securities multi-district and consolidated litigation.

If you wish to discuss this action or have any questions regarding your rights and interests in this case, please immediately contact Wolf Haldenstein by telephone at (800) 575-0735, via e-mail at classmember@whafh.com, or visit our website at  www.whafh.com.

Contact:

Wolf Haldenstein Adler Freeman & Herz LLP
Kevin Cooper, Esq.
Gregory Stone, Director of Case and Financial Analysis
Email: gstone@whafh.com, kcooper@whafh.com or classmember@whafh.com
Tel: (800) 575-0735 or (212) 545-4774

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. 

 

Cision
View original content to download multimedia:http://www.prnewswire.com/news-releases/evolus-inc-class-action-alert-wolf-haldenstein-adler-freeman--herz-llp-announces-that-a--securities--class--action--lawsuit--has--been--filed--in--the--united-states-district-court-for-the-southern-district-of-new-york-on-beha-301163786.html

SOURCE Wolf Haldenstein Adler Freeman & Herz LLP


© PRNewswire 2020
All news about EVOLUS, INC.
01/05EVOLUS, INC. : Termination of a Material Definitive Agreement, Results of Operat..
AQ
2020EVOLUS : Provides Update on United States International Trade Commission Case
AQ
2020US ITC Blocks Imports of Jeuveau Wrinkle Treatment -- Bloomberg
DJ
2020Evolus Provides Update on United States International Trade Commission (ITC) ..
GL
2020EVOLUS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form..
AQ
2020DEADLINE REMINDER : Law Offices of Howard G. Smith Reminds Investors of Looming ..
PR
2020EOLS INVESTOR ALERT : Bronstein, Gewirtz & Grossman, LLC Reminds Evolus, Inc. Sh..
BU
2020THE LAW OFFICES OF FRANK R. CRUZ : Reminds Investors of Looming Deadline in the ..
BU
2020DEADLINE ALERT : Bragar Eagel & Squire, P.C. Reminds Investors That a Class Acti..
BU
2020EVOLUS : ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Evolus, Inc. Investors of Impor..
BU
More news